Literature DB >> 2105909

Adrenergic receptors. Models for regulation of signal transduction processes.

J R Raymond1, M Hnatowich, R J Lefkowitz, M G Caron.   

Abstract

Adrenergic receptors are prototypic models for the study of the relations between structure and function of G protein-coupled receptors. Each receptor is encoded by a distinct gene. These receptors are integral membrane proteins with several striking structural features. They consist of a single subunit containing seven stretches of 20-28 hydrophobic amino acids that represent potential membrane-spanning alpha-helixes. Many of these receptors share considerable amino acid sequence homology, particularly in the transmembrane domains. All of these macromolecules share other similarities that include one or more potential sites of extracellular N-linked glycosylation near the amino terminus and several potential sites of regulatory phosphorylation that are located intracellularly. By using a variety of techniques, it has been demonstrated that various regions of the receptor molecules are critical for different receptor functions. The seven transmembrane regions of the receptors appear to form a ligand-binding pocket. Cysteine residues in the extracellular domains may stabilize the ligand-binding pocket by participating in disulfide bonds. The cytoplasmic domains contain regions capable of interacting with G proteins and various kinases and are therefore important in such processes as signal transduction, receptor-G protein coupling, receptor sequestration, and down-regulation. Finally, regions of these macromolecules may undergo posttranslational modifications important in the regulation of receptor function. Our understanding of these complex relations is constantly evolving and much work remains to be done. Greater understanding of the basic mechanisms involved in G protein-coupled, receptor-mediated signal transduction may provide leads into the nature of certain pathophysiological states.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2105909     DOI: 10.1161/01.hyp.15.2.119

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  8 in total

Review 1.  Molecular biology of adrenergic and dopamine receptors and the study of developmental nephrology.

Authors:  P A Jose; R A Felder; C C Felder; W Y Chan
Journal:  Pediatr Nephrol       Date:  1990-11       Impact factor: 3.714

Review 2.  Beta-adrenergic function in aging. Basic mechanisms and clinical implications.

Authors:  P J Scarpace; N Tumer; S L Mader
Journal:  Drugs Aging       Date:  1991-03       Impact factor: 3.923

Review 3.  Do most antihypertensive agents have a sympatholytic action?

Authors:  J de Champlain
Journal:  Curr Hypertens Rep       Date:  2001-08       Impact factor: 5.369

4.  THE ROLE OF β-ADRENERGIC RECEPTORS IN HEART FAILURE: DIFFERENTIAL REGULATION OF CARDIOTOXICITY AND CARDIOPROTECTION.

Authors:  Daniel Bernstein; Giovanni Fajardo; Mingming Zhao
Journal:  Prog Pediatr Cardiol       Date:  2011-01-01

Review 5.  Modification of beta-adrenoceptor signal transduction pathway by genetic manipulation and heart failure.

Authors:  X Wang; N S Dhalla
Journal:  Mol Cell Biochem       Date:  2000-11       Impact factor: 3.396

6.  Persistent defective coupling of dopamine-1 receptors to G proteins after solubilization from kidney proximal tubules of hypertensive rats.

Authors:  A Sidhu; P Vachvanichsanong; P A Jose; R A Felder
Journal:  J Clin Invest       Date:  1992-03       Impact factor: 14.808

Review 7.  Adenosine A1 and A2 receptors: structure--function relationships.

Authors:  P J van Galen; G L Stiles; G Michaels; K A Jacobson
Journal:  Med Res Rev       Date:  1992-09       Impact factor: 12.944

8.  A nuclear pathway for alpha 1-adrenergic receptor signaling in cardiac cells.

Authors:  A Ardati; M Nemer
Journal:  EMBO J       Date:  1993-12-15       Impact factor: 11.598

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.